US FDA makes EUA changes to Pfizer-BioNTech and Moderna Covid-19 vaccines
The amendment of the EUAs simplifies the vaccination schedule for most individuals.
3M WP
Three regulators accept Bristol Myers’ applications for myeloma therapy
Health Canada accepts Pfizer Canada’s bivalent RSV vaccine for review
Takeda discontinuing in AAV and rare haematology disease markets
Brazil’s ANVISA approves Takeda’s dengue vaccine Qdenga
Pfizer signs agreement to acquire Seagen for $43bn
Teijin Pharma and Novartis sign licence deal for kidney disease candidate
FDA issues continuous manufacturing advice to build an agile pharma industry
